Former World number one Maria Sharapova is expected to face a disciplinary hearing over a drug violation in June.
The beleaguered female tennis star had earlier announced that she was tested positive for banned substance meldonium at Australian Open which she had been taking since 2006 for health issues.
She was provisionally suspended from the sport by the International Tennis Federation and also faces a possible ban of up to four years for her wrongdoings.
Russian Tennis Federation president Shamil Tarpishchev said that Sharapova's disciplinary hearing for doping could be put off until June, but added it was not official, Sport24 reported.
Tarpishchev further revealed that he was in regular contact with the 28-year-old and that she was continuing with her training.
Sharapova's major sponsors Nike, Tag Heuer and Porsche had all distanced themselves from her since her announcement.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app